ARAY
Accuray Incorporated
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Sell
-39/100
Last price
0.26
▼ 0.01 (1.91%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.25
Prev close
0.26
Day high
0.27
Day low
0.24
Volume
1.96M
Market cap
$30.27M
P/E (TTM)
—
52W range
0.22 – 2.10
Day trading desk
Gap from prior close
-3.85%
Prior close 0.26
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
2.60%
0.25 – 0.26
Position in range
100%
Near session high
ATR (14D)
0.04
15.32% of price
Prior day high
0.32
PDH
Prior day low
0.26
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 7.17M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-7.41%
-9.3%
1M
-3.85%
-5.3%
3M
-3.85%
-7.2%
6M
-30.56%
-45.5%
YTD
-69.51%
-83.5%
1Y
-85.38%
-101.1%
3Y
-90.64%
-172.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ARAY open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
5.06M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 23, 26 | PERVAIZ ALI Chief Financial Officer |
STOCK | 19.81K | $0 | Direct |
| Feb 27, 26 | PERALTA LEONEL Chief Operating Officer |
— | 83.72K | — | Direct |
| Feb 20, 26 | MAYER STEVEN F Director |
BUY | 54.88K | $30.88K | Direct |
| Feb 19, 26 | MAYER STEVEN F Director |
BUY | 195.13K | $103.80K | Direct |
| Dec 31, 25 | SCOTT BYRON C Director |
— | 9.43K | — | Direct |
| Nov 28, 25 | CHALKE SANDEEP Officer |
— | 50.31K | — | Direct |
| Nov 28, 25 | PERVAIZ ALI Chief Financial Officer |
— | 44.02K | — | Direct |
| Nov 28, 25 | MAYER STEVEN F Director |
STOCK | 895.39K | $0 | Direct |
| Nov 28, 25 | GALBATO CHAN W Director |
STOCK | 50.00K | $0 | Direct |
| Nov 21, 25 | LE GRAND ANNE BRYCE Director |
— | 56.60K | — | Direct |
| Nov 21, 25 | SCOTT BYRON C Director |
— | 56.60K | — | Direct |
| Nov 21, 25 | NISHIMURA MIKA Director |
— | 56.60K | — | Direct |
| Nov 21, 25 | WHITTERS JOSEPH E Director |
— | 56.60K | — | Direct |
| Nov 21, 25 | MAYER STEVEN F Director |
— | 45.62K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CHALKE SANDEEP |
Officer | 459.81K | Conversion of Exercise of derivative security |
HINDMAN JAMES M |
Director | 294.80K | Conversion of Exercise of derivative security |
HUSS BEVERLY A |
Director | 221.32K | Conversion of Exercise of derivative security |
KILL ROBERT C |
Director | 162.81K | Conversion of Exercise of derivative security |
LE GRAND ANNE BRYCE |
Director | 259.50K | Conversion of Exercise of derivative security |
MAYER STEVEN F |
Director | 1.55M | Purchase |
NISHIMURA MIKA |
Director | 212.66K | Conversion of Exercise of derivative security |
PERVAIZ ALI |
Chief Financial Officer | 366.26K | Stock Award(Grant) |
SCOTT BYRON C |
Director | 158.95K | Conversion of Exercise of derivative security |
WHITTERS JOSEPH E |
Director | 667.66K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$30.27M
Enterprise value$173.52M
Revenue (TTM)$401.95M
Gross profit$111.45M
EBITDA$-3.53M
Net income$-49.19M
EPS (TTM)$-0.40
Free cash flow$10.57M
Total cash$40.62M
Total debt$183.87M
Book value / share$0.35
Shares outstanding119.44M
Float113.68M
Short % of float4.74%
Dividend yield0.00%
Beta (5Y)1.42
Valuation & profitability ratios
Trailing P/E—
Forward P/E-1.06
PEG ratio29.49
Price / sales—
Price / book0.73
EV / revenue0.43
EV / EBITDA-49.18
Gross margin27.73%
Operating margin6.21%
Profit margin-12.24%
Return on equity-80.08%
Return on assets-1.40%
Debt / equity440.96
Current ratio1.50
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $401.95M | $458.50M | $446.55M | $447.61M | -12.3% |
| Operating revenue | $401.95M | $458.50M | $446.55M | $447.61M | -12.3% |
| Cost of revenue | $290.49M | $311.54M | $303.63M | $293.64M | -6.8% |
| Gross profit | $111.45M | $146.97M | $142.92M | $153.96M | -24.2% |
| Research & development | $37.75M | $47.94M | $49.73M | $57.13M | -21.3% |
| Selling, general & admin | $83.97M | $91.19M | $92.69M | $94.45M | -7.9% |
| Total operating expense | $121.72M | $139.13M | $142.42M | $151.58M | -12.5% |
| Operating income | -$10.27M | $7.84M | $504.00K | $2.38M | -231.0% |
| Net interest income | -$34.49M | -$11.76M | -$10.39M | -$10.63M | -193.2% |
| Pre-tax income | -$47.25M | $1.13M | -$11.82M | -$6.79M | -4,266.5% |
| Tax provision | $1.95M | $2.73M | $3.73M | $2.49M | -28.6% |
| Net income | -$49.19M | -$1.59M | -$15.54M | -$9.28M | -2,992.0% |
| Net income to common | -$49.19M | -$1.59M | -$15.54M | -$9.28M | -2,992.0% |
| Basic EPS | -0.40 | -0.02 | -0.16 | -0.10 | -1,900.0% |
| Diluted EPS | -0.40 | -0.02 | -0.16 | -0.10 | -1,900.0% |
| EBIT | -$14.34M | $14.09M | -$196.00K | $3.84M | -201.8% |
| EBITDA | -$6.40M | $20.24M | $5.71M | $8.37M | -131.6% |
| Basic shares | 122.64M | 102.77M | 98.27M | 94.88M | +19.3% |
| Diluted shares | 122.64M | 102.77M | 98.27M | 94.88M | +19.3% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $40.62M | $57.42M | $68.57M | $89.40M | -29.2% |
| Cash & short-term investments | $40.62M | $57.42M | $68.57M | $89.40M | -29.2% |
| Accounts receivable | $67.41M | $83.19M | $92.00M | $74.78M | -19.0% |
| Inventory | $147.07M | $141.02M | $138.32M | $145.15M | +4.3% |
| Total current assets | $287.78M | $317.46M | $323.24M | $338.03M | -9.4% |
| Property, plant & equipment | $54.83M | $61.77M | $58.55M | $46.78M | -11.2% |
| Goodwill & intangibles | $57.91M | $57.82M | $57.73M | $57.89M | +0.2% |
| Total assets | $443.68M | $470.24M | $468.63M | $479.21M | -5.6% |
| Total current liabilities | $191.41M | $192.58M | $195.27M | $198.64M | -0.6% |
| Current debt | $1.50M | $12.73M | $7.76M | $5.72M | -88.2% |
| Long-term debt | $146.37M | $123.79M | $164.40M | $171.56M | +18.2% |
| Total debt | $183.87M | $176.38M | $210.75M | $205.04M | +4.3% |
| Total liabilities | $401.98M | $389.07M | $423.54M | $425.56M | +3.3% |
| Retained earnings | -$568.47M | -$519.27M | -$517.68M | -$502.14M | -9.5% |
| Shareholder equity | $41.70M | $81.17M | $45.08M | $53.66M | -48.6% |
| Working capital | $96.37M | $124.89M | $127.97M | $139.40M | -22.8% |
| Net tangible assets | -$16.21M | $23.35M | -$12.65M | -$4.23M | -169.4% |
| Shares issued | 119.43M | 103.01M | 100.19M | 96.53M | +15.9% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$49.19M | -$1.59M | -$15.54M | -$9.28M | — | -2,992.0% |
| Depreciation & amortisation | $7.94M | $6.15M | $5.91M | $4.53M | — | +29.1% |
| Stock-based compensation | $6.46M | $10.20M | $9.48M | $10.05M | — | -36.7% |
| Change in working capital | $11.86M | -$18.20M | -$21.91M | $4.62M | — | +165.2% |
| Operating cash flow | -$6.98M | $2.86M | -$11.90M | $15.54M | — | -344.1% |
| Capital expenditure | -$12.28M | -$8.52M | -$3.60M | -$12.68M | — | -44.1% |
| Investing cash flow | -$12.28M | -$8.52M | -$3.60M | -$12.68M | — | -44.1% |
| Share buybacks | — | — | — | $0 | $0 | — |
| Financing cash flow | $6.98M | -$4.25M | -$3.95M | -$2.11M | — | +264.1% |
| Free cash flow | -$19.26M | -$5.66M | -$15.51M | $2.86M | — | -240.1% |
| End cash position | $48.77M | $62.13M | $70.39M | $91.20M | — | -21.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $100.92M | $104.84M | $102.24M | $93.94M | $127.54M | -3.7% |
| Operating revenue | $100.92M | $104.84M | $102.24M | $93.94M | $127.54M | -3.7% |
| Cost of revenue | $65.84M | $79.55M | $78.17M | $67.39M | $88.56M | -17.2% |
| Gross profit | $35.08M | $25.29M | $24.07M | $26.55M | $38.98M | +38.7% |
| Research & development | $7.71M | $8.18M | $10.65M | $11.37M | $11.47M | -5.8% |
| Selling, general & admin | $21.10M | $19.66M | $18.91M | $26.49M | $23.27M | +7.3% |
| Total operating expense | $28.81M | $27.84M | $29.56M | $37.86M | $34.74M | +3.5% |
| Operating income | $6.27M | -$2.55M | -$5.49M | -$11.31M | $4.23M | +346.1% |
| Net interest income | -$10.98M | -$8.27M | -$7.46M | -$7.78M | -$3.94M | -32.9% |
| Pre-tax income | -$1.51M | -$11.34M | -$13.20M | -$21.21M | $2.07M | +86.7% |
| Tax provision | $434.00K | $468.00K | $573.00K | $471.00K | $948.00K | -7.3% |
| Net income | -$1.94M | -$11.80M | -$13.77M | -$21.68M | $1.12M | +83.6% |
| Net income to common | -$1.94M | -$11.80M | -$13.77M | -$21.68M | $1.12M | +83.6% |
| Basic EPS | -0.02 | -0.09 | -0.11 | -0.18 | 0.01 | +77.8% |
| Diluted EPS | -0.02 | -0.09 | -0.11 | -0.18 | 0.01 | +77.8% |
| EBIT | $7.19M | -$2.89M | -$5.49M | -$13.15M | $6.30M | +348.7% |
| EBITDA | $9.22M | -$813.00K | -$3.33M | -$11.48M | $7.89M | +1,233.6% |
| Basic shares | 126.39M | 124.30M | 120.97M | 118.95M | 106.70M | +1.7% |
| Diluted shares | 126.39M | 124.30M | 120.97M | 118.95M | 108.89M | +1.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $40.62M | $38.07M | $41.30M | $63.34M | $57.42M | +6.7% |
| Cash & short-term investments | $40.62M | $38.07M | $41.30M | $63.34M | $57.42M | +6.7% |
| Accounts receivable | $67.41M | $64.57M | $60.96M | $54.38M | $83.19M | +4.4% |
| Inventory | $147.07M | $156.63M | $150.96M | $155.50M | $141.02M | -6.1% |
| Total current assets | $287.78M | $293.22M | $292.39M | $303.60M | $317.46M | -1.9% |
| Property, plant & equipment | $54.83M | $57.90M | $60.06M | $61.11M | $61.77M | -5.3% |
| Goodwill & intangibles | $57.91M | $57.88M | $57.85M | $57.82M | $57.82M | +0.1% |
| Total assets | $443.68M | $447.60M | $448.01M | $456.82M | $470.24M | -0.9% |
| Total current liabilities | $191.41M | $205.84M | $199.44M | $194.61M | $192.58M | -7.0% |
| Current debt | $1.50M | $11.16M | $11.11M | $12.85M | $12.73M | -86.6% |
| Long-term debt | $146.37M | $134.02M | $124.78M | $127.32M | $123.79M | +9.2% |
| Total debt | $183.87M | $182.40M | $174.23M | $179.11M | $176.38M | +0.8% |
| Total liabilities | $401.98M | $405.89M | $394.59M | $394.95M | $389.07M | -1.0% |
| Retained earnings | -$568.47M | -$566.52M | -$554.72M | -$540.95M | -$519.27M | -0.3% |
| Shareholder equity | $41.70M | $41.71M | $53.42M | $61.87M | $81.17M | -0.0% |
| Working capital | $96.37M | $87.37M | $92.95M | $108.99M | $124.89M | +10.3% |
| Net tangible assets | -$16.21M | -$16.18M | -$4.43M | $4.04M | $23.35M | -0.2% |
| Shares issued | 119.43M | 118.93M | 118.79M | 113.28M | 112.64M | +0.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$1.94M | -$11.80M | -$13.77M | -$21.68M | $1.12M | +83.6% |
| Depreciation & amortisation | $2.02M | $2.08M | $2.16M | $1.68M | $1.60M | -2.6% |
| Stock-based compensation | $1.68M | $1.38M | $882.00K | $2.52M | $2.82M | +21.9% |
| Change in working capital | -$5.37M | -$48.00K | -$3.80M | $21.08M | -$17.96M | -11,085.4% |
| Operating cash flow | $2.43M | -$5.60M | -$15.99M | $12.18M | -$9.71M | +143.3% |
| Capital expenditure | -$1.35M | -$1.51M | -$5.60M | -$3.82M | -$3.40M | +10.2% |
| Investing cash flow | -$1.35M | -$1.51M | -$5.60M | -$3.82M | -$3.40M | +10.2% |
| Financing cash flow | $3.62M | $4.11M | -$282.00K | -$475.00K | -$5.84M | -11.8% |
| Free cash flow | $1.07M | -$7.11M | -$21.58M | $8.36M | -$13.11M | +115.1% |
| End cash position | $48.77M | $44.44M | $47.87M | $69.93M | $62.13M | +9.7% |
Options analytics
Put / call volume
14.20
Put-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
0.50
+97.3% from spot
ATM implied vol
50.0%
Nearest strike to spot
Skew (10% OTM)
-50.0%
Calls bid over puts
Call volume
5
Contracts, this expiry
Put volume
71
Contracts, this expiry
Heaviest call OI
0.50
0 contracts
Heaviest put OI
0.50
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | — | 0.00 | — |
| Mar 2026 | -0.05 | -0.07 | -35.6% |
| Dec 2025 | -0.11 | -0.11 | +2.2% |
| Sep 2025 | -0.05 | -0.14 | -178.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy0 / 0
Hold1
Sell / Strong sell0 / 0
Held by insiders4.23%
Held by institutions64.55%
Institutions holding144
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.27
-3.93% from price
SMA 20
0.25
-0.79% from price
SMA 50
0.27
-6.23% from price
SMA 100
0.28
-9.91% from price
SMA 200
0.43
-41.62% from price
EMA 12
0.26
-2.73% from price
EMA 26
0.26
-1.65% from price
EMA 50
0.27
-4.13% from price
RSI (14)
47.2
Neutral
MACD (12,26,9)
0.00
Hist 0.00
ATR (14)
0.04
15.71% of price
Realised vol 30D
118.2%
Annualised
Bollinger upper
0.30
20, 2σ
Bollinger lower
0.20
20, 2σ
50 / 200 cross
Death
0.27 vs 0.43
Trend bias
Below 200
-41.62%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
2.55
More volatile than market
Correlation to SPY
0.29
Largely independent
Realised vol 30D
118.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-88.1%
Peak to trough
Max drawdown 5Y
-96.3%
Peak to trough
ATR 14
0.04
15.71% of price
Beta (reported)
1.42
5Y monthly, from filing
Short interest
Shares short
4.94M
Prior 4.67M
Change vs prior
+5.9%
Shorts adding
% of float
4.74%
Normal
% of shares out
4.14%
Against total outstanding
Days to cover
9.4
Crowded exit
Float
113.68M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 12, 26 | Jefferies | DOWNGRADE | Buy | Hold |
| May 7, 26 | BTIG | DOWNGRADE | Buy | Neutral |
| Feb 5, 26 | BTIG | MAINTAINED | Buy | Buy |
| Nov 6, 25 | BTIG | MAINTAINED | Buy | Buy |
| Aug 14, 25 | BTIG | MAINTAINED | Buy | Buy |
| Feb 13, 24 | Roth MKM | INITIATED | — | Buy |
| Oct 4, 23 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Jun 24, 22 | BTIG | MAINTAINED | — | Buy |
| Jun 23, 22 | B. Riley Securities | INITIATED | — | Buy |
| Dec 22, 21 | Loop Capital | INITIATED | — | Buy |
| Jan 21, 20 | BTIG | UPGRADE | Neutral | Buy |
| Nov 1, 18 | Citigroup | UPGRADE | Sell | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-06
Proxy Statements
DEFA14A · 2026-09-18
Offering Registrations
S-3/A · 2026-09-09
Periodic Financial Reports
10-K · 2026-08-27
Proxy Statements
DEF 14A · 2026-08-24
Offering Registrations
S-3/A · 2026-08-21
Corporate Changes & Voting Matters
8-K · 2026-08-19
Proxy Statements
PRE 14A · 2026-08-12
Headlines
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director
PR Newswire · 2d ago
BC-Most Active Stocks
Associated Press · 10d ago
Accuray partners with Samsung NeuroLogica on CyberKnife imaging
Medical Device Network · 10d ago
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform
PR Newswire · 11d ago
What Accuray’s (ARAY) $8 Million RaySearch Deal Means for Its Adaptive Therapy Push
Insider Monkey · 24d ago
Accuray, RaySearch to Collaborate on Adaptive Radiation Therapy
MT Newswires · 27d ago
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
PR Newswire · 27d ago
Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter
Insider Monkey · 40d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.